Companies: 10,795·Total market cap: $144.5T
Big Pharma Split Corp.

Big Pharma Split Corp.

PRM.TOTSXFinancial Services● Active
$13.75
+$0.12(+0.88%)
Market Cap$17933273
P/E Ratio—
52W High$15.5
52W Low$10.71
Net IncomeFinancialsRevenue

Big Pharma Split Corp. (PRM.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PRM.TO · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $4.4M for FY2025 (fiscal year ending 2025-12-31), up 917.0% year-over-year. Net profit margin was 302.7%. Based on available data, Big Pharma Split Corp. has been profitable since at least 2017.

FY2025 Net Income$4.4M▲ +917.0% YoY
Trailing 12M (TTM)$3.9Mtrailing 4 quarters sum
Net Profit Margin302.7%$4.4M ÷ $1.5M
YoY Change+917.0%—
5-Year CAGR+75.3%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2017

▸ FMP /income-statement · Annual · PRM.TO net income history · PRM.TO profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$4.4M▲ +917.0%302.7%
FY2024Loss−$538,624▼ 285.6%-29.1%
FY2023Loss−$139,680▼ 104.4%-44.8%
FY2022$3.1M▼ 35.2%80.1%
FY2021$4.9M▲ +1728.6%90.6%

Net income vs peers (Financial Services)

#CompanyNet IncomeYoY
#1
Big Pharma Split Corp.
Big Pharma Split Corp.YOU
PRM.TO
$4.4M+917.0%
#2
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-B
$66.97B-24.8%#3
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-A
$66.97B-24.8%#4
JPMorgan Chase & Co.
JPMorgan Chase & Co.
JPM
$57.05B-2.4%#5
Visa Inc.
Visa Inc.
V
$20.06B+1.6%#6
Mastercard Incorporated
Mastercard Incorporated
MA
$14.97B+16.3%
Financial Services · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Big Pharma Split Corp. (PRM.TO) reported net income of $4.4M for FY2025 (fiscal year ending 2025-12-31), up 917.0% year-over-year. The net profit margin was 302.7% — meaning the company kept $3.03 of every dollar of revenue as profit.

Based on available data, Big Pharma Split Corp. has been profitable since at least 2017. Net income reached a peak of $4.9M in FY2021. Data available for 9 fiscal years.

Big Pharma Split Corp.'s net profit margin was 302.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Big Pharma Split Corp. net worth" — the company's market capitalization is a separate figure from PRM.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

PRM.TO net income · 5 questions

Big Pharma Split Corp. is profitable. The company reported net income of $4.4M for FY2025, a net profit margin of 302.7%. Net income was up 917.0% year-over-year. Based on available data, Big Pharma Split Corp. has been profitable since at least 2017.

is PRM.TO profitabledoes PRM.TO make a profitPRM.TO profitabilityPRM.TO profitable company

▸ Source: FMP /income-statement · GAAP · Big Pharma Split Corp. · Big Pharma Split Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026